InvestorsHub Logo
Followers 10
Posts 1064
Boards Moderated 0
Alias Born 11/24/2007

Re: jbog post# 14996

Friday, 11/13/2015 8:22:56 PM

Friday, November 13, 2015 8:22:56 PM

Post# of 20689
Well I am just saying that AMPH killed the golden goose by aggressively cutting price to gain market share. A 4B market has become a 400M market with only 2 generics approved is just stunning. In retrospect, Sndz was very generous with its 25% discount when they are the only generic. Cutting price to gain market share is a terrible idea especially when you are the sole generic.